Key points are not available for this paper at this time.
Abstract Background IPL devices emit a wide range of wavelengths that can be absorbed by different chromophores in the skin. Selective destruction of a specific chromophore with minimal side effects is controlled by wavelength, pulse duration, and fluence. Aim This study aims to evaluate the treatment of vascular and pigmented lesions using narrow‐band Intense Pulsed Light (IPL) with Advanced Fluorescence Technology (AFT), which offers more efficient energy usage per pulse to increase safety, and improve clinical outcomes. Methods A retrospective analysis of data from 100 patients treated with narrow‐band IPL for vascular and pigmented lesions. Efficacy was measured by the Global Aesthetic Improvement Scale (GAIS) and Patient Satisfaction Scale (0–10). Safety was assessed by evaluating pain levels and adverse events. Results Mean GAIS scores were 8.02 ± 0.84 for vascular and 8.14 ± 0.9 for pigmented lesions with no significant difference between groups ( p =0.49, α =0.05). Patient satisfaction correlated with GAIS scores (correlation coefficient 0.8). No pain was reported and two patients experienced temporary and transient side effects. Conclusion Overall, the advanced IPL treatments provided favorable outcomes for vascular and pigmented lesions.
Avdulaj Arminda (Mon,) studied this question.